Array Biopharma Inc (NASDAQ:ARRY) Under Investor Investigation over Potential Wrongdoing
An investigation on behalf of current long-term investors in shares of Array Biopharma Inc (NASDAQ:ARRY) was announced over potential breaches of fiduciary duties by certain officers and directors at Array Biopharma Inc.
View full press release